Close it

Would you like to become a TBEC member? Please fill out the form below.

By becoming a TBEC member, you agree to endorse the values and the principles of the TB Europe Coalition, and agree with its membership rights and responsibilities.

Membership is free of charge.

TBEC membership rights

TBEC membership responsibilities











Posts tagged "EECA"
Civil Society Capacity Building for DR-TB Regional Meeting

Civil Society Capacity Building for DR-TB Regional Meeting

When new, effective medicines providing safe treatment for widespread debilitating diseases, it is vitally important to ensure that everyone who needs such medicines has access to them. It was with this aim therefore that TBEC held a regional meeting on civil society capacity building for DR-TB. Existing TB treatments are incredibly gruelling for the patient, but medical innovations (shorter or safer treatments, new medicines, or more exact methods of diagnosis) can genuinely relieve a patient’s suffering. But what use are such innovations if patients aren’t able to access them? What use are new medicines if there’s no way for hospitals to buy them or any way to prescribe that they are needed? Any measurement of the success of innovative treatments has to be countered by an assessment of their accessibility. When everyone has access to new treatments, we can start to talk about how successful they are. Guidelines on DR-TB Treatment The recent WHO recommendations on drug-resistant TB (DR-TB) are the first in a long time that provide a genuine possibility to start to improve the treatment of DR-TB by using innovative and more effective medicines with less debilitating side effects. It is therefore vital that we do not waste time; More…

Regional Meeting on Civil Society Capacity Building for DR-TB treatment in EECA

TB Europe Coalition (TBEC) is organising a  regional meeting on capacity building of civil society to advocate for safe and affordable drug-resistant TB (DR-TB) treatment in the region of Eastern Europe and Central Asia. This will take place from 18th-20th June 2019 in Kiev, Ukraine. We particularly welcome applications from representatives of patient groups, organizations working with vulnerable groups of people living with TB or TB/HIV, as and representatives of civil society organizations which advocate for access to TB/HIV treatment. The deadline for submissions has passed. Meeting Objectives: Increase understanding of the principles of the new WHO guidelines on DR-TB for achieving quality people-centered and rights-based TB care; Map barriers to the launch of the new WHO DR-TB guidelines in different countries and define the role of civil society in overcoming these barriers; Define ways for civil society actions to build demand among people undergoing TB treatment for the use of the new and safe medicines; Increase understanding of the role of informed consent in relation to treatment options as a human-rights based tool and to support civil society to improve practices of informed consent in their home countries and manage ethical considerations. Increase understanding of tools for monitoring of side More…

CfP: Consultants to develop a framework for the roadmap on cooperation between National TB programs, health providers and civil society in the EECA region (TB-REP2.0)

CfP: Consultants to develop a framework for the roadmap on cooperation between National TB programs, health providers and civil society in the EECA region (TB-REP2.0)

TBEC announce a call for individual consultants to develop framework for the roadmap on cooperation between National TB programs, health providers and civil society in the EECA region within TB-REP2.0 project TB Europe Coalition invites individual consultants to indicate their interest to develop framework for the roadmap on cooperation between National TB programs, health providers and civil society in the EECA region in the framework of the implementation of the current tasks of the Global Fund Multi-Country Program “Advancing People-Centered Quality TB Care – From the New Model of Care Towards Improving DR-TB Early Detection and Treatment Outcomes” (TB-REP 2.0). The consultant would be expected to: Develop the framework roadmap to be applied in specific countries of the EECA region. The framework roadmap should be informed by the epidemiological, political situation of the East Europe and Central Asia region and be in line with existing recommendations for the region such as of WHO and Stop TB Partnership. Develop the template of the MoU or joint statement between NTPs and civil society. More detailed information is provided in the Request for Expression of Interest and Terms of Reference. Deadlines for this have now closed. This webpage is the product of an activity that More…

Find and Support - Interview with Daniel Kashnitsky

Find and Support – Interview with Daniel Kashnitsky

This interview first appeared in the March 2019 edition of the “Don’t Fly Away” magazine, Odessa Way Home Charity Fund, Ukraine  Let us introduce our guest, Daniel Kashnitsky, Capacity Building Manager from TB Europe Coalition. Daniel came to Odessa for a three-day visit to do research into our experience in active finding of missing people with tuberculosis. Daniel found time to answer a few questions for our journal. Daniel, tell us about TB Europe Coalition and its main activities. TB Europe Coalition (TBEC) was created as a network of civil society organizations working in the WHO European Region in 2009. In 2018, the TBEC secretariat was founded in Kiev, Ukraine to be closer to the region of Eastern Europe and Central Asia (EECA), where some of TBEC’s main projects and the most affected countries of the WHO European Region are located. TBEC has two main objectives – to develop the capacity of activists in advocacy, including supporting more local activities as well as civil society campaigns at national and international level, not to mention developing organizations’ capacity in direct service provision. TBEC has three thematic areas: budget advocacy – here we particularly mean the transition of TB services to national More…

Giving MDR-TB Patients a New Lease on Life

Giving MDR-TB Patients a New Lease on Life

Multidrug-resistant tuberculosis (MDR-TB) can be successfully treated today; however, the treatment course can take as long as two years and side effects can be severe if not appropriately addressed. The rate of MDR-TB treatment success is largely dependent on a patient’s socioeconomic circumstances as patients from marginalized groups are particularly vulnerable to dropping out of treatment. That is why ensuring patients’ adherence to TB treatment through a patient-centered approach that engages communities and civil society organizations, is critical to the success of MDR-TB treatment outcomes. Consistent with the principles of the WHO End TB Strategy, Project Hope’s interventions in Tajikistan (within the framework of the Global Fund to fight AIDS, Tuberculosis and Malaria TB grant) have provided a robust foundation for building a strong coalition in which communities and civil society organizations play a crucial role in combatting TB. Trained members of civil society and non-governmental organizations (NGO) have a unique capacity through patient education and psychosocial support to reach out to their communities to ensure that TB and MDR-TB patients make full recovery. One such patient for whom Project HOPE’s community-based initiatives were life-changing is Alisher Latipov. A family man from the Spitamen district in Tajikistan’s Sughd region, Alisher More…

GOOD NEWS from KAZAKHSTAN:  Tuberculosis on decrease in the last 10 years

GOOD NEWS from KAZAKHSTAN: Tuberculosis on decrease in the last 10 years

According to the Ministry of Health and Social Development of the Republic of Kazakhstan, the country made a good progress in the tuberculosis incidence and mortality. Over the last 10 years the incidence of TB in Kazakhstan decreased by 2.2 times and the mortality rate decreased by 5 times. In 2015, the incidence decreased by 11.9% and amounted to 58.5 per 100 thousand population (in 2014 – 66.4), the mortality rate decreased by 22.4% and amounted to 3.8 per 100 thousand population (in 2014 – 4.9) (Health Ministry) The effective treatment of newly diagnosed patients with sensitive tuberculosis in 2015 improved and reached 87.6% compared to 86.4% in 2014 (WHO standard – 85%). “Today, all regions of the country are provided with modern equipment for diagnosis of tuberculosis, including its drug-resistant forms. The country has sufficient level of necessary medicines, “the ministry informed. This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food More…

High level event on sustainability of TB and HIV responses held in Tbilisi, Georgia

High level event on sustainability of TB and HIV responses held in Tbilisi, Georgia

From 28-30 September, a TBEC delegation attended a high level dialogue in Tbilisi ‘Road to Success’. We joined technical experts, civil society, donors, international agencies and Ministers to discuss the transition of some countries from donor support to domestic funding in Eastern Europe and Central Asia. The high level regional dialogue, hosted by the Georgian government and organised by the Eurasian Harm Reduction Network, the Global Fund, UNAIDS, UNDP, UNODS, UNFPA and WHO Europe is the first in a series of national dialogues which will develop plans for each countries for transition from Global Fund funding of TB and HIV programmes in the region. Although domestic financing of TB and HIV responses have been increasing throughout the years, countries are still highly dependent on Global Fund support, especially for services to key populations (81% dependent on external support), TB diagnostics like functioning of GeneXpert (94% dependent on Global Fund) and 2nd line TB drugs (66% dependent on Global Fund support). With figures such as these, in order to reach the Sustainable Development Goals’ targets of ending TB and HIV as public health threats by 2030, we need not only to sustain but also scale up our responses in the coming More…

The Third Consultation on Global Fund 2017-2021 Strategy took place in Istanbul, TBEC was there!

The Third Consultation on Global Fund 2017-2021 Strategy took place in Istanbul, TBEC was there!

July 21-22, 2015 in Istanbul (Turkey) held a technical consultation on the transition to domestic funding of HIV and TB responses and their programmatic sustainability in Eastern Europe and Central Asia (EECA). The meeting was initiated and carried out by EHRN and with the support of Global Fund. The consultation was attended by representatives of governmental, non-governmental national and network organizations from EECA (ECU PLWH, TB Europe Coalition, ENPUD), as well as members of several delegations on the board of the Global Fund, UN system organizations and donor agencies. The main purpose of the consultation was to discuss the realistic planning structure to ensure the programmatic sustainability of EECA countries that making the transition to the domestic funding instead of funding from the Global Fund, as well as the preparation of draft of Framework for Sustainability and Transition. Key issues included the principles, sources of technical support, algorithms and mechanisms that will help to ensure a successful transition to national funding sources. The objectives of consultative meeting were to review the experience of other countries in transition, to define key elements and timelines to be included in a Framework for Sustainability. It will further serve as guidance for all stakeholders More…

Key positions of civil society and communities from the EECA region on the new Global Fund Strategy 2017–2021

Key positions of civil society and communities from the EECA region on the new Global Fund Strategy 2017–2021

On 12-13 July 2014, civil society and communities’ representatives met in Chisinau, Moldova for the Consultation meeting in order to develop key positions and suggestions that should be reflected in the Global Fund’s strategy for 2017-2021. The consultation was organized by the Communities Delegation on the Board of The Global Fund in co-operation with the Eurasian Harm Reduction Network. Civil society and community participants were representing wide regional networks, such as EHRN, ECUO, ECOM, ENPUD, EWNA, SWAN, TBEC, ITPCru, Delegations on the Board of the Global Fund, such as the Communities Delegation, the Developed and Developing Country NGO Delegations and the EECA Delegation. The delegates concluded their key messages and topics relating to the context of the fighting against TB and HIV in Easter Europe and Central Asia. The summary document: “Key themes and positions on the Global Fund Strategy 2017–2021 as stated by civil society representatives from Eastern Europe and Central Asia” covers the following themes: Transition to domestic funding and Global Fund investment in middle-income countries Continuum of HIV and TB services for key affected populations Treatment for TB, HIV, conditions caused by long-term ART, co-infections and access to medications Human rights, gender equality and vulnerable groups Community More…

TBEC participates in the Global Fund consultation on regional TB strategy for EECA

TBEC participates in the Global Fund consultation on regional TB strategy for EECA

  On 13th November, the Global Fund Secretariat organised a consultation at WHO Europe headquarters in Copenhagen to define a regional TB strategy for the implementation of its New Funding Model (NFM) in Eastern Europe and Central Asia (EECA). The consultation gathered a wide range of stakeholders including the Stop TB Partnership, the Global Fund Secretariat, WHO Country offices across the region, USAID, civil society groups like the TB Europe Coalition, the Eurasian Harm Reduction Network, MSF, the International Federation of the Red Cross, KNCV Tuberculosis Foundation, the International HIV/AIDS Alliance Ukraine and the Eastern Europe and Central Asia Union of People Living with HIV. The aim of the consultation was to define a limited set of priorities on what the Global Fund can do most effectively in the region while generating the greatest impact. Indeed, a Global Fund modelling of funding allocations under the NFM indicated that just 3% of total resources would be allocated to EECA. This represents a 50% decrease of what was previously available. Investment therefore needs to be directed towards most effective and targeted interventions. A similar consultation was held previsouly in Geneva on HIV. Two priorities were identified for EECA: increased access to ARVs More…

Comprehensive report on drug-resistant tuberculosis launches in the UK

Comprehensive report on drug-resistant tuberculosis launches in the UK

This week, the All Party Parliamentary Group on Global Tuberculosis (UK) launched a report – Drug-Resistant Tuberculosis: Old Disease, New Threat – highlighting the increasing concern that exists about growing rates of drug-resistant TB (DR-TB). The comprehensive piece was compiled after considerable time spent on processing both written and oral evidence from a number of experts in the field.The report identifies the main challenges facing not only the UK but also the world and outlines a series of recommendations for swift action where the biggest impact can be made. Importantly, the report highlights that it is not only developing countries that are witnessing a rise in DR-TB. Significantly, it makes note of the fact that 15 of the 27 highest burden countries are in the WHO European region. Almost 80,000 multi-drug resistant TB (MDR-TB) cases occurred in the region in 2011, accounting for nearly a quarter of all MDR-TB cases worldwide. In Russia, Belarus and Ukraine between nine to 32% of new cases and more than 50% of previously treated cases have MDR-TB. These figures should drive our leaders both domestically and at an EU level to take action. Not only are DR-TB strains more difficult to treat but they More…

'Here I Am' campaign illustrates successful impact of the Global Fund in fighting HIV, TB and Malaria

‘Here I Am’ campaign illustrates successful impact of the Global Fund in fighting HIV, TB and Malaria

The ‘Here I Am’ campaign, a global call on world leaders to save millions of lives by supporting a fully funded Global Fund, has been releasing a number of engaging video testimonials to highlight the positive impact that the Global Fund has had in fighting AIDS, TB and Malaria. The videos account first hand the struggles people have gone through when faced with either of these three diseases but also, importantly, the fact that many of them now have the help and hope they need to overcome them and enable them to live healthy and happy lives.  By featuring the stories from all over the world of those directly affected and the turnaround in their fortunes thanks to the Global Fund support, and combining these with campaign ambassadors, online actions, and on-the-ground mobilisations, the campaign is aiming to, build the collective power to end three of the world’s most deadly diseases. One of these powerful testimonies comes from Yevhen Selin from Ukraine. Yevhen tells of his experiences as a teenager with injecting drugs and addiction and how this led to both periods in jail as a young man. Having served half a sentence, Yevhen left prison determined to give up More…

wink.pink